Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Multiple Sclerosis

  Free Subscription


Articles published in Clin Exp Immunol

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    March 2021
  1. HAQUE R, Kim Y, Park K, Jang H, et al
    Altered distributions in circulating follicular helper and follicular regulatory T cells accountable for imbalanced cytokine production in multiple sclerosis.
    Clin Exp Immunol. 2021 Mar 24. doi: 10.1111/cei.13596.
    PubMed     Abstract available


    September 2020
  2. JORGENSEN LO, Hyrlov KH, Elkjaer ML, Weber AB, et al
    Cladribine modifies functional properties of microglia.
    Clin Exp Immunol. 2020;201:328-340.
    PubMed     Abstract available


    August 2020
  3. YACOV N, Kafri P, Salem Y, Propheta-Meiran O, et al
    MOSPD2 is a therapeutic target for the treatment of CNS inflammation.
    Clin Exp Immunol. 2020;201:105-120.
    PubMed     Abstract available


    July 2020
  4. UZAWA A, Mori M, Masuda H, Ohtani R, et al
    Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder.
    Clin Exp Immunol. 2020 Jul 8. doi: 10.1111/cei.13487.
    PubMed     Abstract available


    August 2019
  5. RUIZ-ARGUELLES GJ, Olivares-Gazca JC, Olivares-Gazca M, Leon-Pena AA, et al
    Self-reported changes in the expanded disability status scale (EDSS) score in patients with multiple sclerosis after autologous stem cell transplants: real-world data from a single center.
    Clin Exp Immunol. 2019 Aug 8. doi: 10.1111/cei.13358.
    PubMed     Abstract available


    June 2019
  6. MELDOLESI J
    Extracellular vesicles, news about their role in immune cells: physiology, pathology and diseases.
    Clin Exp Immunol. 2019;196:318-327.
    PubMed     Abstract available


    May 2019
  7. AQEL SI, Kraus EE, Jena N, Kumari V, et al
    Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes Treg development.
    Clin Exp Immunol. 2019;196:215-225.
    PubMed     Abstract available


    August 2018
  8. LI Z, Richards S, Surks HK, Jacobs A, et al
    Clinical Pharmacology of Alemtuzumab, an Anti-CD52 Immunomodulator, in Multiple Sclerosis.
    Clin Exp Immunol. 2018 Aug 24. doi: 10.1111/cei.13208.
    PubMed     Abstract available


    July 2018
  9. FUJIWARA M, Anstadt EJ, Flynn B, Morse K, et al
    Enhanced TLR2 responses in multiple sclerosis.
    Clin Exp Immunol. 2018 Jul 24. doi: 10.1111/cei.13150.
    PubMed     Abstract available


  10. GORTER RP, Nutma E, Jahreibeta MC, de Jonge JC, et al
    Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis.
    Clin Exp Immunol. 2018 Jul 17. doi: 10.1111/cei.13186.
    PubMed     Abstract available


    November 2017
  11. KAPLAN B, Golderman S, Ganelin-Cohen E, Miniovitch A, et al
    IMMUNOGLOBULIN FREE LIGHT CHAINS IN SALIVA: A potential marker for disease activity in multiple sclerosis.
    Clin Exp Immunol. 2017 Nov 30. doi: 10.1111/cei.13086.
    PubMed     Abstract available


  12. PAZHOUHANDEH M, Sahraian MA, Siadat SD, Fateh A, et al
    A Systems Medicine Approach Reveals Disordered Immune System and Lipid Metabolism in Multiple Sclerosis Patients.
    Clin Exp Immunol. 2017 Nov 30. doi: 10.1111/cei.13087.
    PubMed     Abstract available


    May 2017
  13. KARNELL FG, Lin D, Motley S, Duhen T, et al
    Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation.
    Clin Exp Immunol. 2017 May 12. doi: 10.1111/cei.12985.
    PubMed     Abstract available


    March 2017
  14. WANG Y, He D, Liang H, Yang D, et al
    The identification of upregulated ebv-mir-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis.
    Clin Exp Immunol. 2017 Mar 2. doi: 10.1111/cei.12954.
    PubMed     Abstract available


    November 2016
  15. DE OLIVEIRA GL, Ferreira AF, Gasparotto EP, Kashima S, et al
    Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.
    Clin Exp Immunol. 2016 Nov 7. doi: 10.1111/cei.12895.
    PubMed     Abstract available


    September 2016
  16. JONES AP, Kermode AG, Lucas RM, Carroll WM, et al
    Circulating immune cells in multiple sclerosis.
    Clin Exp Immunol. 2016 Sep 30. doi: 10.1111/cei.12878.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: